Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02273986 · ClinicalTrials.gov registry record · Phase 1

Drug-Drug Interaction Study in Health Adult Volunteers

A Phase 1 study of Healthy, sponsored by Kowa Research Institute.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT02273986 is a Phase 1 study of Healthy that has completed, run by Kowa Research Institute. The registered enrollment target is 20 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02273986, a Phase 1 study of Healthy, has completed, sponsored by Kowa Research Institute.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the effects of K-877 on the pharmacokinetics of digoxin in healthy adult volunteers.

Conditions Studied

Interventions

  • DRUG Digoxin
  • DRUG K-877

Study Locations (1)

Texas

  • PPD - Austin

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2014-08
Phase Phase 1

Sponsor

Kowa Research Institute

44 total trials

What the Registry Record Tells You About NCT02273986

The ClinicalTrials.gov registry entry for NCT02273986 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Digoxin is the first listed.

NCT02273986 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02273986 about?

NCT02273986 is a clinical study titled "Drug-Drug Interaction Study in Health Adult Volunteers". The purpose of this study is to assess the effects of K-877 on the pharmacokinetics of digoxin in healthy adult volunteers.

What is the current status of trial NCT02273986?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2014-08.

What conditions does trial NCT02273986 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02273986?

The interventions under investigation include: Digoxin (DRUG), K-877 (DRUG).

Who is sponsoring clinical trial NCT02273986?

This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02273986 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.